Can we read this as success. With the SPP closed the only way to get exposure to this emerging story is by adding/buying on market.
I don`t expect the buyers to wait long before they realise sub .07c or even .08c is a bargain.
"Completion of the current trial of NovoSorb in
full thickness wounds. With 8 of the required 10
patients recruited and treated, observations to date
in relation to the NovoSorb dressing indicate that the
performance has been excellent. Completion of the
trial and release of results is expected during Q3 2013"
Add to My Watchlist
What is My Watchlist?